Alkermes (ALKS) Tax Rate Growth (5y) (2015 - 2026)
Alkermes (ALKS) Tax Rate Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,974.00 |
| Mar 31, 2026 | 1,276.00 |
| Dec 31, 2025 | 2,059.00 |
| Sep 30, 2025 | -8,825.00 |
| Jun 30, 2025 | 3,118.00 |
| Mar 31, 2025 | 3,526.00 |
| Dec 31, 2024 | -82,269.00 |
| Sep 30, 2024 | 1,399.00 |
| Jun 30, 2024 | 2,291.00 |
| Mar 31, 2024 | 1,321.00 |
| Dec 31, 2023 | -136,946.00 |
| Sep 30, 2023 | 310.00 |
| Jun 30, 2023 | 3,453.00 |
| Mar 31, 2023 | -1,303.00 |
| Dec 31, 2022 | 13,469.00 |
| Sep 30, 2022 | 640.00 |
| Jun 30, 2022 | 350.00 |
| Mar 31, 2022 | 1,510.00 |
| Dec 31, 2021 | -9,740.00 |
| Sep 30, 2021 | -1,331.00 |